[TRANSLATION NOTE] Based on the company name and stock code (007660), ISUPETASYS operates in the Korean market. The consolidated financial statements indicate multi-entity operations, but specific business segment details are not provided in the available DART filing data. The company name suggests potential involvement in systems or technology-related business activities, though the exact nature of operations and key business segments cannot be definitively determined from the financial data alone.
ISUPETASYS demonstrates strong growth momentum. Consolidated revenue increased 23.9% year-over-year to KRW 836.9 billion in FY2024 (ended Dec 31, 2024) from KRW 675.3 billion in FY2023. This follows a 5.0% increase in the prior year.
Operating profit showed robust improvement to KRW 101.9 billion in FY2024, up 63.9% from KRW 62.2 billion in FY2023, though still below the FY2022 level of KRW 116.6 billion. The operating margin expanded to 12.2% in FY2024 from 9.2% in FY2023. Net profit reached KRW 74.0 billion in FY2024, up 55.1% from KRW 47.7 billion in FY2023, representing an 8.8% net margin.
Total assets grew 26.1% to KRW 790.1 billion, with current assets surging 36.2% to KRW 522.7 billion. Total debt increased to KRW 462.6 billion from KRW 359.7 billion, resulting in a debt-to-equity ratio of 141% (up from 135%). The debt-to-asset ratio stands at 58.5%. Retained earnings grew significantly to KRW 172.3 billion from KRW 114.4 billion, reflecting solid profit accumulation.
The DART filing data provided does not include information on ownership structure, controlling shareholders, or foreign ownership percentage. This information would typically be found in separate disclosure documents not included in this dataset.
Rising Leverage Risk: Total liabilities increased 28.6% in FY2024, outpacing equity growth of 22.8%. Both current liabilities (up 29.9% to KRW 377.4 billion) and non-current liabilities (up 23.3% to KRW 85.2 billion) expanded significantly, indicating accelerated borrowing that could pressure future cash flows if revenue growth decelerates.
Operating Profit Volatility: Despite FY2024's recovery, operating profit remains 12.6% below the FY2022 peak of KRW 116.6 billion, demonstrating vulnerability to cyclical or market pressures that previously compressed margins by nearly half between FY2022 and FY2023.
ISUPETASYS presents a growth-recovery story with 24% revenue growth and expanding margins in FY2024, but accelerating debt levels (29% increase) and historical profit volatility warrant close monitoring of leverage management and competitive positioning sustainability.
⚠️ This profile is AI-generated from DART filings. Quantitative data is reliable. Qualitative summaries should be verified against original Korean filings for investment decisions.